These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21112807)

  • 21. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
    Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
    Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators.
    Harizi H; Gualde N
    Cell Mol Immunol; 2006 Aug; 3(4):271-7. PubMed ID: 16978535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-33 - cytokine of dual function or novel alarmin?
    Haraldsen G; Balogh J; Pollheimer J; Sponheim J; Küchler AM
    Trends Immunol; 2009 May; 30(5):227-33. PubMed ID: 19359217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biology of IL-36 cytokines and their role in disease.
    Gresnigt MS; van de Veerdonk FL
    Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of IL -9 and IL-33 in mast cells.
    Sabatino G; Nicoletti M; Neri G; Saggini A; Rosati M; Conti F; Cianchetti E; Toniato E; Fulcheri M; Caraffa A; Antinolfi P; Frydas S; Pandolfi F; Potalivo G; Galzio R; Conti P; Theoharides TC
    J Biol Regul Homeost Agents; 2012; 26(4):577-86. PubMed ID: 23241108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 Family Cytokines: General Characteristics, Pathogenic Microorganisms, Receptors, and Signalling Pathways.
    Behzadi P; Behzadi E; Ranjbar R
    Acta Microbiol Immunol Hung; 2016 Mar; 63(1):1-25. PubMed ID: 27020866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response.
    Mingomataj EÇ; Bakiri AH
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):97-113. PubMed ID: 26450621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New inflammation modulator interleukins . Therapeutic implications].
    Lupuşoru CE; Tarţău L; Ghiciuc C
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):24-9. PubMed ID: 12635355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis-like skin lesions are dependent on IL-23 but develop in the absence of IL-22 in a model mouse.
    Takaishi M; Nakajima K; Ouyang W; Sano S
    J Dermatol Sci; 2014 Mar; 73(3):261-4. PubMed ID: 24315761
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytokine storm in acute pancreatitis.
    Makhija R; Kingsnorth AN
    J Hepatobiliary Pancreat Surg; 2002; 9(4):401-10. PubMed ID: 12483260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes.
    Banerjee M; Saxena M
    Clin Chim Acta; 2012 Aug; 413(15-16):1163-70. PubMed ID: 22521751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-21: a new modulator of immunity, infection, and cancer.
    Brandt K; Singh PB; Bulfone-Paus S; Rückert R
    Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biology of IL-21 and the IL-21 receptor.
    Mehta DS; Wurster AL; Grusby MJ
    Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perimenstrual alterations in type-1/type-2 cytokine balance of normal women.
    Agarwal SK; Marshall GD
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):222-8. PubMed ID: 10507267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukins (ILs), a fascinating family of cytokines. Part II: ILs from IL-20 to IL-38.
    Fietta P; Costa E; Delsante G
    Theor Biol Forum; 2015; 108(1-2):19-40. PubMed ID: 27167908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-10 Family and Tuberculosis: An Old Story Renewed.
    Abdalla AE; Lambert N; Duan X; Xie J
    Int J Biol Sci; 2016; 12(6):710-7. PubMed ID: 27194948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19.
    Fietta P; Costa E; Delsante G
    Theor Biol Forum; 2014; 107(1-2):13-45. PubMed ID: 25936211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IL-2 cytokine family in cancer immunotherapy.
    Sim GC; Radvanyi L
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism.
    Nakagome K; Imamura M; Kawahata K; Harada H; Okunishi K; Matsumoto T; Sasaki O; Tanaka R; Kano MR; Chang H; Hanawa H; Miyazaki J; Yamamoto K; Dohi M
    J Immunol; 2011 Nov; 187(10):5077-89. PubMed ID: 21998459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.